# Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants

> **NCT01326611** · PHASE4 · COMPLETED · sponsor: **Zekai Tahir Burak Women's Health Research and Education Hospital** · enrollment: 273 (actual)

## Conditions studied

- Chronic Lung Disease

## Interventions

- **DRUG:** Clarithromycin
- **DRUG:** Dextrose

## Key facts

- **NCT ID:** NCT01326611
- **Lead sponsor:** Zekai Tahir Burak Women's Health Research and Education Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-09
- **Final completion:** 2010-12
- **Target enrollment:** 273 (ACTUAL)
- **Last updated:** 2011-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01326611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01326611, "Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01326611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*